Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Facial aesthetic procedures improve quality of life for transgender individuals.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

Transgender and gender-diverse teens need specialized skin and mental health care.

This commentary highlights that transgender patients are often dissatisfied with standard hormone replacement therapy for hair-related goals, emphasizing the need for dermatologists to provide informed guidance and tailor treatments.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

This review reports that transgender patients undergoing hormone therapy may experience acne differently, necessitating tailored treatments that take into account skin dryness and the potential need for maintenance topical treatments.

This study aims to evaluate the prevalence of androgenetic alopecia in transgender men undergoing testosterone therapy, noting that such hormone treatment can lead to dermatological issues that significantly affect their quality of life. Results are not reported in the abstract.

This article highlights the gap between medically necessary dermatologic gender-affirming procedures and insurance coverage for transgender and gender diverse service members in the US Military, and discusses how dermatologists can support gender-affirming care and address existing healthcare disparities.

This study found that topical minoxidil significantly enhanced facial hair growth in transgender individuals assigned female at birth undergoing gender affirming hormone therapy, with improvements most notable after six months of use.

In this study, researchers reported that transgender men undergoing testosterone therapy experienced varying rates of alopecia (hair loss), which may be influenced by the duration of treatment, genetic factors, and family history.

This source describes two cases of hair transplantation in transgender patients with Androgenetic Alopecia, showing good results using Follicular Unit Extraction and Follicular Unit Transplantation techniques, highlighting the need for more research specific to this population.

This article discusses the role of dermatopathologists in addressing healthcare inequities faced by transgender patients and reports no new clinical findings; it emphasizes the importance of accurate data management to prevent misdiagnosis and insurance issues.

This paper reviews hair restoration surgery options for transgender patients and reports no new clinical results; the authors emphasize tailoring treatment plans to individual facial features and hair characteristics.

This abstract lacks findings or results and does not provide a summary about any specific research study or topic.

This review discusses transgender healthcare needs in gynecology, including creating a welcoming clinic environment and understanding treatments, but it reports no new clinical findings.

This study describes the creation and two-year experience of a pioneering dermatological practice exclusively serving transgender and non-binary patients to address their unique dermatological concerns and promote healthcare equity, based on a retrospective analysis of 114 patients at a public hospital.

This study found that transgender and gender diverse patients on masculinizing hormone therapy had 2.5 times the rate of androgenetic alopecia compared to cisgender women.

This study demonstrated that intact adult human dermal papillae can induce hair growth when implanted into mouse hair follicles, highlighting their potential for advancing hair follicle biology and therapeutic approaches.

This study found that combining polybrene and a ROCK inhibitor can effectively expand human keratinocyte stem/progenitor cells carrying a transgene, aiding their use in regenerative medicine.

This study demonstrated that an AR-EGFP transgene can restore AR function and fertility in Sertoli cell-specific AR knockout mice, highlighting its potential use in understanding androgen receptor functions.

This narrative review discusses the initiation and monitoring of gender-affirming hormone therapy in Australia, noting standard testosterone use for trans men and estradiol with anti-androgens for trans women, emphasizing the importance of monitoring cardiovascular and bone health.

This case report describes two transgender men using subdermal testosterone pellets for gender affirmation, finding they tolerated the treatment, but one returned to injections; firm conclusions on pellets' suitability require further study.

In this discussion, Dr. Jailyn Avila emphasizes the importance of understanding transgender identities and implementing inclusive practices, like using correct pronouns, to improve emergency care for transgender patients, who often avoid healthcare due to fears of discrimination.

Among transgender men, this study reported a case of breast cancer found incidentally after a gender-affirming mastectomy, despite common lower breast cancer risks in this population, highlighting the importance of cancer screening and careful consideration of hormone therapy management in transgender and gender-diverse individuals.

This review highlights the dermatological needs of transgender and gender diverse individuals in Australia, emphasizing the role of dermatologists in managing skin and hair conditions related to gender affirmation and hormone therapy.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

This study identified that transgender patients face barriers in accessing oral healthcare, including discrimination and harassment, leading to increased stress, poorer oral health, and a diminished quality of life related to oral health.

This review discusses hormonal treatment strategies for both binary and non-binary transgender people, highlighting the need for personalized approaches and the importance of future research on long-term outcomes.

This study investigated hair enhancement treatments used by transgender men in the U.S. and found that while 90% used testosterone therapy, 44.1% sought additional facial hair enhancement options such as topical minoxidil, despite significant safety concerns reported by 77.3% of participants.